BriaCell Therapeutics Corp. [NASDAQ: BCTX] loss -14.88% or -0.9 points to close at $5.15 with a heavy trading volume of 3992686 shares. The company report on June 3, 2021 that IIROC Trading Resumption – BCT.
Trading resumes in:.
Company: BriaCell Therapeutics Corp.
It opened the trading session at $5.81, the shares rose to $5.83 and dropped to $5.00, the range by which the price of stock traded the whole day. The daily chart for BCTX points out that the company has recorded 14.29% gains over the past six months. However, it is still -83.27% lower than its most recent low trading price.
If we look at the average trading volume of 3.45M shares, BCTX reached to a volume of 3992686 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about BriaCell Therapeutics Corp. [BCTX]:
The Average True Range (ATR) for BriaCell Therapeutics Corp. is set at 0.74
Trading performance analysis for BCTX stock
BriaCell Therapeutics Corp. [BCTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 62.97. With this latest performance, BCTX shares gained by 51.92% in over the last four-week period, additionally plugging by 14.29% over the last 6 months – not to mention a drop of -47.98% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BCTX stock in for the last two-week period is set at 65.48, with the RSI for the last a single of trading hit 67.13, and the three-weeks RSI is set at 62.62 for BriaCell Therapeutics Corp. [BCTX]. The present Moving Average for the last 50 days of trading for this stock 3.58, while it was recorded at 4.77 for the last single week of trading, and 4.80 for the last 200 days.
BriaCell Therapeutics Corp. [BCTX]: A deeper dive into fundamental analysis
An analysis of insider ownership at BriaCell Therapeutics Corp. [BCTX]
There are presently around $2 million, or 34.13% of BCTX stock, in the hands of institutional investors. The top three institutional holders of BCTX stocks are: SABBY MANAGEMENT, LLC with ownership of 160,182, which is approximately New of the company’s market cap and around 22.56% of the total institutional ownership; REDMOND ASSET MANAGEMENT, LLC, holding 131,731 shares of the stock with an approximate value of $0.68 million in BCTX stocks shares; and ZEKE CAPITAL ADVISORS, LLC, currently with $0.23 million in BCTX stock with ownership of nearly New of the company’s market capitalization.
10 institutional holders increased their position in BriaCell Therapeutics Corp. [NASDAQ:BCTX] by around 375,051 shares. Additionally, 0 investors decreased positions by around 0 shares, while 0 investors held positions by with 0 shares. The mentioned changes placed institutional holdings at 375,051 shares, according to the latest SEC report filing. BCTX stock had 10 new institutional investments in for a total of 375,051 shares, while 0 institutional investors sold positions of 0 shares during the same period.